A trans-acting factor, p40, of human T-cell leukemia virus type I profoundly potentiated the function of the enhancer from simian virus 40 but not polyomavirus and Rous sarcoma and murine sarcoma viruses. This trans-activation was seen in a limited repertoire of cells, in contrast to trans-activation of the human T-celi leukemia virus type I enhancer by p40.
. This function was demonstrated to be mediated by a 21-base-pair (bp) motif sequence within the U3 region which functions as an enhancer and to be indispensable for the replication of HTLV-I (28) . On the other hand, HTLV-I has no typical oncogene and is randomly integrated into the cellular genome (24) . The mechanism of cellular transformation by HTLV-I could, therefore, be different from that by other retroviruses, but clear information on the transformation mechanism has not yet been demonstrated. However, products of pX are suggested to play a crucial role in transformation. Hence, it is of importance to elucidate the entire function of p40 with respect to leukemogenesis. During our studies on the trans-acting function of p40, we noted that p40 modulates the function of the simian virus 40 (SV40) early promoter. In the present study, we report that p40 trans-activates the SV40 enhancer in some cell lines.
To assess the trans-acting effects of p40 on cognate and noncognate viral promoters, we used a set of plasmids containing the bacterial chloramphenicol acetyltransferase (CAT) gene under the control of various viral promoter units (Fig. 1) . The promoter units used were the HTLV-I LTR, the Rous sarcoma virus (RSV) LTR, and the SV40 early promoter. They were independently linked to the CAT gene, generating pCHL4 (22) , pRSVcat (11) , and pSV2cat (12) Schematic representation of CAT constructs. pSV2cat and pRSVcat have been described elsewhere (11, 12) . pSVOcat (12) and pSVlCcat (22) , derived from pSV2cat, have deletions of the entire SV40 promoter unit and most of the 72-bp direct repeat enhancer sequence, respectively. pCHL4 contains a 630-bp fragment of the HTLV-I LTR inserted via HindlIl linkers at the HindIIl site of pSVOcat (22) . An enhancerless mutant (pdHL4) of the HTLV-I LTR was previously constructed by removal of a 320-bp fragment between the NdeI sites in pCHL4 and introduction of a ClaI linker (22) . The HTLV-I core promoter is still present in pdHL4. pMEHL4 carries a 200-bp enhancer fragment of MSV at the ClaI site of pdHL4 in the sense orientation (22) . A 233-bp fragment (PvuII-NcoI) from the SV40 promoter region, which contains the 72-bp direct repeat enhancer (boxes with arrowheads) and GC box (three repeated arrows) sequences, was inserted into pdHL4 at the ClaI site in the sense and antisense orientations, generating pSEHL4 and pSERHL4, respectively. The same enhancer fragment was introduced at the BamHI site located downstreamn from the CAT-coding region of pdHL4 in the sense and antisense orientations, yielding pSEBHLA and pSEBRHL4, respectively. pWEN CAT contains a 633-bp fragment encompassing the polyomavirus enhancer in a backbone CAT vector of pAjOCAT2 (18) .
either the HTLV-I LTR or other distinct viral promoter units (Table 1) . Cotransfection of pSV2cat with pMAXneo resulted in significantly increased (5-to 20-fold) CAT activity in the human T-cell lines Jurkat, HSB2, and Karpas T and in an erythroleukemic cell line, K562. The level of CAT activity varied in different cell lines, but we considered that p40 had a significant effect when CAT expression with pMAXneo was more than three times that with pMAXneo/M, as indicated by the boldface type in Table 1, except with  pCHL4. p40 has been shown to act directly or indirectly on the 21-bp enhancer sequence in the U3 region of the HTLV-I LTR (28) . The SV40 promoter unit used contains an enhancer consisting of a 72-bp direct repeat, GC boxes, and the core promoter. Accordingly, we next examined which element of the SV40 promoter unit is responsible for transactivation by p40. For this, we used pSVlCcat as an enhancerless mutant in which a sequence covering most of the 72-bp direct repeat in pSV2cat is deleted but the GC boxes are still present (Fig. 1) . This plasmid was introduced with either pMAXneo or pMAXneo/M into the cells in which p40 trans-activated CAT expression from pSV2cat, and CAT activity was assayed. The results showed that p40 had no effect on the enhancerless SV40 promoter in pSVlCcat and that the conversion of [14C]chloramphenicol was as low as it was with pSV2cat and pMAXneo/M in all the cell lines tested except for K562, in which the level of CAT activity after cotransfection with pSVlCcat and pMAXneo was 20-fold lower than it was after cotransfection with pSV2cat and pMAXneo/M (Fig. 2) . These CAT genes are driven by heterologous promoters containing the SV40 enhancer. For construction of these vectors, a 233-bp NcoI-PvuII fragment from the SV40 enhancer region was introduced into pdHL4, which has the HTLV-I LTR lacking the U3 enhancer, at the Clal site in the sense and antisense orientations, yielding pSEHL4 and pSERHL4, respectively (Fig. 1) . These hybrid plasmids were similarly cotransfected along with pMAXneo into Jurkat, HSB2, Karpas T, and K562 cells, and the CAT activities were compared with those with pMAXneo/M. In all four cell lines, p40 induced a 4-to 10-fold increase in activity (Fig. 2) . This enhancing effect was independent of the orientation of the inserted enhancer fragment of SV40. Moreover, enhancement by p40 was demonstrated with other hybrid plasmids (pSEBHL4 and pSEBRHL4) carrying the SV40 enhancer fragment at the BamHI site located downstream from the CAT-coding region (Fig. 1) , although the magnitudes of the enhancement were lower than with pSEHL4 or pSERHL4 (Fig. 2) . These results clearly showed that the p40 enhancing effect is also independent of the location of the cis-acting element. With these plasmids, however, no increase by p40 was seen in U937 and Raji cell lines, as with pSV2cat (Fig.  2) . Although the SV40 fragment used as an enhancer contains the GC boxes as well as the 72-bp enhancer sequence, the 72-bp enhancer sequence seems to be responsible for facilitating gene expression mediated by p40 in a trans-acting manner, because the enhancement by p40 was not dependent on the orientation or location of the SV40 element, whereas the GC box function is reported to be dependent on its location (31) .
The present study is an attempt to gain insight into the mechanism of trans-activation by HTLV-I p40, which is a nuclear molecule that is probably crucial for leukemogenesis. Examination of the activities of several distinct viral promoter units showed that the SV40 enhancer as well as the HTLV-I LTR was responsive to trans-activation mediated by p40. These results suggested that the activation could occur at a transcriptional level. In addition, we found that trans-activation of the SV40 enhancer was restricted to certain cell lines.
It is unlikely that the high level of CAT activity from the plasmids bearing the SV40 element in the presence of p40 in some cells was due to an increase in the copy number of the plasmids, because the activation by p40 was observed with hybrid plasmids carrying the SV40 fragment, which is inadequate for replication, and because these cells did not express the SV40 large T antigen, which is absolutely required for the replication of SV40. (15) .
A computer search has identified a pentanucleotide, CT-GAC, that is present in enhancers of SV40 and HTLV-I (our unpublished data). This sequence is also found in the 5' regulatory regions of the interleukin 2, interleukin 2 receptor, and adenovirus E3 genes, which are all trans-activated by HTLV-I p40 or the equivalent product of the closely related HTLV-II; the adenovirus E3 gene is also transactivated by its own viral ElA product via a cellular factor (5). In the SV40 enhancer, this sequence is located at the end of an element designated as P (7) and is also present in the element designated as A by Herr (20, 30) . These tyrosine kinases may lead to the expression of some cellular genes, including the gene for a possible factor that, after modification by HTLV-I p40, interacts with the SV40 enhancer. This mechanism could explain why only a few cell lines show trans-activation of the SV40 enhancer by p40. 
